Skip to main content
OpenTrials
Completed

NCT Number: NCT04862754

Effect of Interval Training on Arterial Stiffness in Women With Hypertension

this study is aiming to assess the chronic effect of the interval training program on arterial stiffness in women with hypertension

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Arterial Stiffness

Age range

40 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of physical therapy

Cairo, 17452, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • physically inactive
  • BMI 30-40
  • Stage 1 and 2 hypertension
  • Elevated BP as systolic BP ≥130 mm Hg and/or diastolic BP ≥85 mm Hg measured at the brachial artery.

Exclusion criteria

  • Medications known to affect weight or appetite
  • Any disease associated with exercise intolerance.
  • Women were taking hormone replacement therapy

Treatment and study plan

interval training exercise

Other

interval training exercise

Primary outcomes

  1. Central arterial stiffness measurements (Pulse Wave Velocity [PWV], augmentation index )

    Time frame: two months

    Pulse wave analysis (PWA) of the women in the two groups: pre and post treatment for pulse wave velocity (PWV) and augmentation index(AIx)

    Pulse Wave Velocity [PWV], augmentation index (AIx @75HR) and resting heart rate were measured using analysis equipment which called Non-invasive blood pressure measurement system using "Mobil-O-Graph 24h PWA " with Hypertension Management Software Client Server (HMS-CS 4.3). PWA was performed using an oscillometric Mobil-O-Graph R 24 h PWA Monitor device (I.E.M GmbH, Germany) with integrated ARCSolver® software

Secondary outcomes

  1. blood lipid profile

    Time frame: two months

    blood analysis will be used to measure lipid profile (high and low-density lipoprotein, cholesterol, triglyceride)

  2. interleukin 6

    Time frame: two months

    blood analysis will be used to measure interleukin 6

  3. blood pressure (systolic and diastolic)

    Time frame: two months

    resting Blood pressure was monitored from the right arm using an automated digital electronic BP monitor (Omron digital BP monitor, Model 11 EM 403c; Tokyo Japan).

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Apr 28, 2021
Registry last updated
Mar 15, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.